Adipose tissue in bone regeneration - stem cell source and beyond

Lăbuşcă, Luminiţa

doi:10.4252/wjsc.v14.i6.372

Cited by 6 publications

(2 citation statements)

References 167 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…MSCs assist regeneration mainly by means of the trophic and immunomodulatory effect generated by their paracrine activity. Adipose-derived mesenchymal cells (ADSCs) are MSCs derived from adipose tissue considered to be a convenient source for RM strategies due to their large-scale availability and phenotypic properties [ 8 ]. ADSCs were shown to express immunomodulatory and trophic effects in vitro as well as in vivo in an animal model investigating autoimmune and traumatic hearing loss [ 9 ].…”

Section: Introductionmentioning

confidence: 99%

Towards Regenerative Audiology: Immune Modulation of Adipose-Derived Mesenchymal Cells Preconditioned with Citric Acid-Coated Antioxidant-Functionalized Magnetic Nanoparticles

Cumpata

Peptanariu²,

Lungoci³

et al. 2023

Medicina

Self Cite

View full text Add to dashboard Cite

Introduction and Background: Based on stem cells, bioactive molecules and supportive structures, regenerative medicine (RM) is promising for its potential impact on field of hearing loss by offering innovative solutions for hair cell rescue. Nanotechnology has recently been regarded as a powerful tool for accelerating the efficiency of RM therapeutic solutions. Adipose-derived mesenchymal cells (ADSCs) have already been tested in clinical trials for their regenerative and immunomodulatory potential in various medical fields; however, the advancement to bedside treatment has proven to be tedious. Innovative solutions are expected to circumvent regulatory and manufacturing issues related to living cell-based therapies. The objectives of the study were to test if human primary ADSCs preconditioned with magnetic nanoparticles coated with citric acid and functionalized with antioxidant protocatechuic acid (MNP-CA-PCA) retain their phenotypic features and if conditioned media elicit immune responses in vitro. MNP-CA-PCA was synthesized and characterized regarding size, colloidal stability as well as antioxidant release profile. Human primary ADSCs preconditioned with MNP-CA-PCA were tested for viability, surface marker expression and mesenchymal lineage differentiation potential. Conditioned media (CM) from ADSCs treated with MNP-CA-PCA were tested for Il-6 and IL-8 cytokine release using ELISA and inhibition of lectin-stimulated peripheral blood monocyte proliferation. Results: MNP-CA-PCA-preconditioned ADSCs display good viability and retain their specific mesenchymal stem cell phenotype. CM from ADSCs conditioned with MNP-CA-PCA do not display increased inflammatory cytokine release and do not induce proliferation of allergen-stimulated allogeneic peripheral blood monocytes in vitro. Conclusions: While further in vitro and in vivo tests are needed to validate these findings, the present results indicated that CM from ADSCs preconditioned with MNP-CA-PCA could be developed as possible cell-free therapies for rescuing auditory hair cells.

show abstract

Section: Introductionmentioning

confidence: 99%

Towards Regenerative Audiology: Immune Modulation of Adipose-Derived Mesenchymal Cells Preconditioned with Citric Acid-Coated Antioxidant-Functionalized Magnetic Nanoparticles

Cumpata

Peptanariu²,

Lungoci³

et al. 2023

Medicina

Self Cite

View full text Add to dashboard Cite

show abstract

“…37 These cells can be obtained, isolated, and cultured from adipose tissue to generate an injectable derivative with an immunophenotype consistent with that of mesenchymal stem cells (MSCs), thus opening a variety of potential applications in regenerative medicine. 12,14,33,39,40,54,56,64,66,70,71 Despite a myriad of proposed benefits, specific processing and harvest protocols can lead to substantial variation in the molecular and chemical makeup of the injectate. 43 In orthopaedics specifically, these adipose-derived therapies have been used as an adjunct to arthroscopic knee surgery, 8 for the treatment of aseptic nonunion, 55 and for various forms of tendinopathy and acute tendon injury.…”

Section: Introductionmentioning

confidence: 99%